Sort
64,565 grants matching “drug discovery”
NEW CHEMICAL ENTITIES AND UNIQUE TARGETS FOR HCMV
$738,784University Of Michigan At Ann Arbor · P01 · FY2000 · AI
Defective lysosome acidification in dystrophic neurites in Alzheimer's disease contributes to failure of autophagy
$738,781Matthew Schrag · Vanderbilt University Medical Center · R56 · FY2022 · AG
Exploration, conservation, & development of marine biodiversity in Fiji
$738,771Mark E Hay · Georgia Institute Of Technology · U01 · FY2011 · TW
A GIP Companion Drug for Enhancing Metabolic Benefits of Long-Acting GLP-1
$738,741Krishna Kumar · Velum, Inc. · R42 · FY2022 · AG
Cartilage-Bone-Synovium MPS: Musculoskeletal Disease Biology in Space
$738,674Alan J Grodzinsky · Massachusetts Institute Of Technology · UH3 · FY2019 · TR
Cartilage-Bone-Synovium MPS: Musculoskeletal Disease Biology in Space
$738,674Alan J Grodzinsky · Massachusetts Institute Of Technology · UH3 · FY2020 · TR
GUARD: A global unbiased antimicrobial discovery platform
$738,580Arul Jayaraman · Texas Engineering Experiment Station · R01 · FY2024 · AI
Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biology
$738,557Charles M. Rice · Rockefeller University · R01 · FY2025 · AI
Pharmacogenetics and Cardiovascular Events
$738,515University Of Washington · R01 · FY2003 · HL
Evolution and inhibition of carbapenemase in beta-lactam resistance
$738,466Yu Chen · University Of South Florida · R01 · FY2022 · AI
Homogeneous Screening Assay for Cytokine Receptor Modulators
$738,401Jeffrey R Spencer · Stategics, Inc. · R44 · FY2020 · TR
High-Resolution, Parallelized Imaging of Freely Swimming Zebrafish with a Gigapixel Microscope
$738,353Mark Harfouche · Ramona Optics, Inc. · R44 · FY2019 · OD
Multi-omics profiling of individual exosomes for origin-tracing, biomarker discovery, and biological function characterization
$738,347Yuchao Chen · Wellsim Biomedical Technologies, Inc. · R44 · FY2025 · GM
Peptide Biomarkers for Alzheimer Disease
$738,287Jing Zhang · University Of Washington · R01 · FY2018 · AG
Small molecule Hsp90 inhibitors in AD treatment
$738,284Gabriela Chiosis · Sloan-Kettering Inst Can Research · U01 · FY2010 · AG
Leadership, Planning and Evaluation
$738,164Raphael E. Pollock · Ohio State University · P30 · FY2024 · CA
Leadership, Planning and Evaluation
$738,161Raphael E. Pollock · Ohio State University · P30 · FY2022 · CA
Leadership, Planning and Evaluation
$738,161Raphael E. Pollock · Ohio State University · P30 · FY2021 · CA
Leadership, Planning and Evaluation
$738,161Raphael E. Pollock · Ohio State University · P30 · FY2023 · CA
Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands
$738,119Victoria Ahn · Confometrx, Inc. · R44 · FY2021 · MH
Complex 3-Dimensional in vitro Human Skin Tissue Models for Scleroderma
$738,102Joana M Murad · Celdara Medical, Llc · R44 · FY2019 · AR
Muscarinic modulation of RDoC constructs in primate behavior and fronto-striatal circuits
$738,042Thilo Womelsdorf · Vanderbilt University · R01 · FY2023 · MH
Targeting the chromatin binding domains of BPTF for neuroblastoma epigenetic therapy
$738,024Marcus Fischer · St. Jude Children'S Research Hospital · R01 · FY2025 · CA
STRUCTURAL MOTIFS IN MEMBRANE PROTEINS
$738,023Yale University · P01 · FY2002 · GM
IGF::OT::IGF QUALITY ASSURANCE/ QUALITY CONTROL (QA/QC)
$738,015Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2016 · AI